Cmv drugs

The drug of choice for the treatment of CMV disease is intravenous ganciclovir, although valganciclovir may be used for nonsevere CMV treatment in selected cases.

For prophylaxis, an anti-CMV drug is administered to patients at risk for CMV infection who have no evidence of CMV viremia (DNAemia) or disease. In the pre-emptive strategy, antiviral therapy is

We found some antiviral drugs (ganciclovir, valaciclovir and aciclovir) reduced the risk of CMV disease, death due to CMV disease, and

Prescribed for CMV Infection, CMV Prophylaxis, CMV Retinitis. ganciclovir may also be used for purposes not listed in this medication guide. Prescription

Schedule II Drug Use and CMV driver safety.

Use for the prevention of cytomegalovirus (CMV) disease in transplant recipients at risk for CMV disease. drugs, over-the-counter medicines

Data on the efficacy of valaciclovir from transplant patients (~200) at high risk of CMV disease (e.g. donor CMV positive/recipient CMV negative or use of anti-

Maribavir is in late stages of development for CMV treatment and may provide a safer alternative to currently available anti-CMV drugs. Promising CMV vaccine candidates and adoptive cell therapy approaches are under evaluation. CMV immune monitoring assays are predicted to play a more central role in our clinical decision making.

The drug of choice for the treatment of CMV disease is intravenous ganciclovir, although valganciclovir may be used for nonsevere CMV treatment